ethyl 4,4,4-trifluorobut-2-ynoate Cas:79424-03-6

We are ethyl 4,4,4-trifluorobut-2-ynoate CAS:79424-03-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


ethyl 4,4,4-trifluorobut-2-ynoate

Synonyms:
ethyl trifluoromethylpropiolate
ethyl 4,4,4-trifluoro-2-butynoate
ethyl 4,4,4-trifluobut-2-ynoate
ethyl 4,4,4-trifluoro-2-bytynoate
4,4,4-trifluoro-2-butynoic acid ethyl ester
ethyl 3-trifluoromethylpropynoate
 
Molecular Formula:  C6H5F3O2
Molecular weight:166.09800
 
Density: 1.162 g/mL at 25ºC(lit.)
Boiling point: 96-98ºC(lit.)
Flash point: 43 °F
Refractive index: n20/D 1.350(lit.)
Storage conditions: Keep Cold

 
Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.
 



Market News: But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals.(E)-N-methyl-N-(3-(3-thienyl)-2-propenyl)-1-naphthalenemethanamine manufacturer.The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion. imidazo[1,2-a]pyrimidine,hydrochloride supplier Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. (5S)-4-(allyloxy)-5-(tert-butyl)-3-methylenedihydrofuran-2(3H)-one producer

Related Products
Product Name
3-acetylpyridine Cas:350-03-8 View Details
Trans,trans-2,4-heptadienal Cas:4313-03-5 View Details
Bis(cyclopentadienyl)ruthenium(II) Cas:1287-13-4 View Details
Allylchloro[1,3-bis(2,6-di-i-propylphenyl)imidazol-2-ylidene]palladium (ii) Cas:478980-03-9 manufacturer SOLVENT BLACK 27 Cas:12237-22-8 manufacturer Triphosphopyridine nucleotide disodium salt manufacturer AMINOGUANIDINE HYDROCHLORIDE Cas:1937-19-5 manufacturer 1-Aminohydantoin Hydrochloride Cas:2827-56-7 manufacturer